Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ALECTINIB vs ALFUZOSIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ALECTINIB vs ALFUZOSIN: Safety Overview

Metric ALECTINIB ALFUZOSIN
Total FAERS Reports 9,161 2,562
Deaths Reported 1,055 193
Death Rate 11.5% 7.5%
Hospitalizations 1,553 1,244
Average Patient Age 60.7 yrs 62.8 yrs
% Female Patients 60.2% 6.7%
FDA Approval Date Dec 11, 2015 Aug 10, 2012
Manufacturer Genentech, Inc. Rising Pharma Holdings, Inc.
Route ORAL ORAL
Marketing Status Prescription Prescription